BioSig Technologies CFO Steve Chaussy departs; Steve Buhaly appointed as new CFO
Streamex Corp.
CFO Steve Chaussy terminated Feb 2, 2023; severance includes $200k cash bonus upon 10-K filing and up to 325,000 restricted shares subject to plan approval.
New CFO Steve Buhaly appointed, effective Feb 6, 2023; annual base salary $100k, eligible for stock options to acquire 250,000 shares.
Filing amends prior 8-K to correct description of Chaussy's severance agreement and attach correct exhibit.
On February 2, 2023, the BioSig Technologies, Inc. (the “ Company ”) entered into a General Release and Severance Agreement (the “ Release Agreement ”) with Steve Chaussy, Chief Financial Officer of the Company, pursuant to which Mr. Chaussy’s employment with the Company will terminate at such point when his services are no longer required
On February 2, 2023, the Board appointed Mr. Steve Buhaly as the Chief Financial Officer of the Company, whose employment will commence on February 6, 2023.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Steve Chaussy was terminated as Chief Financial Officer at Streamex Corp..
Action
terminated
Role
Chief Financial Officer
Exact text from the filing
On February 2, 2023, the BioSig Technologies, Inc. (the “ Company ”) entered into a General Release and Severance Agreement (the “ Release Agreement ”) with Steve Chaussy, Chief Financial Officer of the Company, pursuant to which Mr. Chaussy’s employment with the Company will terminate at such point when his services are no longer required
Steve Buhaly was appointed as Chief Financial Officer at Streamex Corp..
Action
appointed
Role
Chief Financial Officer
Exact text from the filing
On February 2, 2023, the Board appointed Mr. Steve Buhaly as the Chief Financial Officer of the Company, whose employment will commence on February 6, 2023.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.